218 related articles for article (PubMed ID: 31872418)
21. Hotspot Mutations Detectable by Next-generation Sequencing in Exhaled Breath Condensates from Patients with Lung Cancer.
Youssef O; Knuuttila A; Piirilä P; Böhling T; Sarhadi V; Knuutila S
Anticancer Res; 2018 Oct; 38(10):5627-5634. PubMed ID: 30275180
[TBL] [Abstract][Full Text] [Related]
22. Exome sequencing on malignant meningiomas identified mutations in neurofibromatosis type 2 (NF2) and meningioma 1 (MN1) genes.
Zhang X; Jia H; Lu Y; Dong C; Hou J; Wang Z; Wang F; Zhong H; Wang L; Wang K
Discov Med; 2014 Dec; 18(101):301-311. PubMed ID: 25549701
[TBL] [Abstract][Full Text] [Related]
23. Comparative analysis of the NF2, TP53, PTEN, KRAS, NRAS and HRAS genes in sporadic and radiation-induced human meningiomas.
Joachim T; Ram Z; Rappaport ZH; Simon M; Schramm J; Wiestler OD; von Deimling A
Int J Cancer; 2001 Oct; 94(2):218-21. PubMed ID: 11668501
[TBL] [Abstract][Full Text] [Related]
24. Clinical significance of multiple gene detection with a 22-gene panel in formalin-fixed paraffin-embedded specimens of 207 colorectal cancer patients.
Gao XH; Yu GY; Hong YG; Lian W; Chouhan H; Xu Y; Liu LJ; Bai CG; Zhang W
Int J Clin Oncol; 2019 Feb; 24(2):141-152. PubMed ID: 30612269
[TBL] [Abstract][Full Text] [Related]
25. Differences in Mutational Profile between Follicular Thyroid Carcinoma and Follicular Thyroid Adenoma Identified Using Next Generation Sequencing.
Borowczyk M; Szczepanek-Parulska E; Dębicki S; Budny B; Verburg FA; Filipowicz D; Więckowska B; Janicka-Jedyńska M; Gil L; Ziemnicka K; Ruchała M
Int J Mol Sci; 2019 Jun; 20(13):. PubMed ID: 31248021
[TBL] [Abstract][Full Text] [Related]
26. Mutation profiling of anaplastic ependymoma grade III by Ion Proton next generation DNA sequencing.
Butt E; Alyami S; Nageeti T; Saeed M; AlQuthami K; Bouazzaoui A; Athar M; Abduljaleel Z; Al-Allaf F; Taher M
F1000Res; 2019; 8():613. PubMed ID: 32612806
[No Abstract] [Full Text] [Related]
27. Progestin-associated shift of meningioma mutational landscape.
Peyre M; Gaillard S; de Marcellus C; Giry M; Bielle F; Villa C; Boch AL; Loiseau H; Baussart B; Cazabat L; Raffin-Sanson ML; Sanson M; Kalamarides M
Ann Oncol; 2018 Mar; 29(3):681-686. PubMed ID: 29206892
[TBL] [Abstract][Full Text] [Related]
28. STK11 mutation status is associated with decreased survival in meningiomas.
Gill CM; Loewenstern J; Rutland JW; Arib H; Pain M; Umphlett M; Kinoshita Y; McBride RB; Bederson J; Donovan M; Sebra R; Fowkes M; Shrivastava RK
Neurol Sci; 2020 Sep; 41(9):2585-2589. PubMed ID: 32253637
[TBL] [Abstract][Full Text] [Related]
29. Angiomatous meningiomas have a distinct genetic profile with multiple chromosomal polysomies including polysomy of chromosome 5.
Abedalthagafi MS; Merrill PH; Bi WL; Jones RT; Listewnik ML; Ramkissoon SH; Thorner AR; Dunn IF; Beroukhim R; Alexander BM; Brastianos PK; Francis JM; Folkerth RD; Ligon KL; Van Hummelen P; Ligon AH; Santagata S
Oncotarget; 2014 Nov; 5(21):10596-606. PubMed ID: 25347344
[TBL] [Abstract][Full Text] [Related]
30. Non-NF2 mutations have a key effect on inhibitory immune checkpoints and tumor pathogenesis in skull base meningiomas.
Hao S; Huang G; Feng J; Li D; Wang K; Wang L; Wu Z; Wan H; Zhang L; Zhang J
J Neurooncol; 2019 Aug; 144(1):11-20. PubMed ID: 31177425
[TBL] [Abstract][Full Text] [Related]
31. Wide spetcrum mutational analysis of metastatic renal cell cancer: a retrospective next generation sequencing approach.
Fiorentino M; Gruppioni E; Massari F; Giunchi F; Altimari A; Ciccarese C; Bimbatti D; Scarpa A; Iacovelli R; Porta C; Virinder S; Tortora G; Artibani W; Schiavina R; Ardizzoni A; Brunelli M; Knuutila S; Martignoni G
Oncotarget; 2017 Jan; 8(5):7328-7335. PubMed ID: 27741505
[TBL] [Abstract][Full Text] [Related]
32. Next-generation sequencing-based multi-gene mutation profiling of solid tumors using fine needle aspiration samples: promises and challenges for routine clinical diagnostics.
Kanagal-Shamanna R; Portier BP; Singh RR; Routbort MJ; Aldape KD; Handal BA; Rahimi H; Reddy NG; Barkoh BA; Mishra BM; Paladugu AV; Manekia JH; Kalhor N; Chowdhuri SR; Staerkel GA; Medeiros LJ; Luthra R; Patel KP
Mod Pathol; 2014 Feb; 27(2):314-27. PubMed ID: 23907151
[TBL] [Abstract][Full Text] [Related]
33. Fibroblast growth factor receptor-3 expression in meningiomas with stimulation of proliferation by the phosphoinositide 3 kinase-Akt pathway.
Johnson MD; O'Connell MJ; Pilcher W; Reeder JE
J Neurosurg; 2010 May; 112(5):934-9. PubMed ID: 19698046
[TBL] [Abstract][Full Text] [Related]
34. Whole exome sequencing in a case of sporadic multiple meningioma reveals shared NF2, FAM109B, and TPRXL mutations, together with unique SMARCB1 alterations in a subset of tumor nodules.
Torres-Martín M; Kusak ME; Isla A; Burbano RR; Pinto GR; Melendez B; Castresana JS; Rey JA
Cancer Genet; 2015 Jun; 208(6):327-32. PubMed ID: 25981829
[TBL] [Abstract][Full Text] [Related]
35. Targeted deep sequencing of mucinous ovarian tumors reveals multiple overlapping RAS-pathway activating mutations in borderline and cancerous neoplasms.
Mackenzie R; Kommoss S; Winterhoff BJ; Kipp BR; Garcia JJ; Voss J; Halling K; Karnezis A; Senz J; Yang W; Prigge ES; Reuschenbach M; Doeberitz MV; Gilks BC; Huntsman DG; Bakkum-Gamez J; McAlpine JN; Anglesio MS
BMC Cancer; 2015 May; 15():415. PubMed ID: 25986173
[TBL] [Abstract][Full Text] [Related]
36. Analysis of CDKN2A gene alterations in recurrent and non-recurrent meningioma.
Guyot A; Duchesne M; Robert S; Lia AS; Derouault P; Scaon E; Lemnos L; Salle H; Durand K; Labrousse F
J Neurooncol; 2019 Dec; 145(3):449-459. PubMed ID: 31729637
[TBL] [Abstract][Full Text] [Related]
37. Identification of novel fusion transcripts in meningioma.
Khan AB; Gadot R; Shetty A; Bayley JC; Hadley CC; Cardenas MF; Jalali A; Harmanci AS; Harmanci AO; Wheeler DA; Klisch TJ; Patel AJ
J Neurooncol; 2020 Sep; 149(2):219-230. PubMed ID: 32949309
[TBL] [Abstract][Full Text] [Related]
38. Targeted next-generation sequencing identifies clinically relevant somatic mutations in a large cohort of inflammatory breast cancer.
Liang X; Vacher S; Boulai A; Bernard V; Baulande S; Bohec M; Bièche I; Lerebours F; Callens C
Breast Cancer Res; 2018 Aug; 20(1):88. PubMed ID: 30086764
[TBL] [Abstract][Full Text] [Related]
39. Somatic mutation landscape in a cohort of meningiomas that have undergone grade progression.
Cain SA; Pope B; Mangiola S; Mantamadiotis T; Drummond KJ
BMC Cancer; 2023 Mar; 23(1):216. PubMed ID: 36882706
[TBL] [Abstract][Full Text] [Related]
40. Mutational signature of extracranial meningioma metastases and their respective primary tumors.
Biczok A; Thorsteinsdottir J; Karschnia P; Ruf VC; Tonn JC; Herms J; Schichor C; Dorostkar MM
Acta Neuropathol Commun; 2023 Jan; 11(1):12. PubMed ID: 36641486
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
